Twenty-four-week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine/lamivudine as first-line antiretroviral therapy: a randomized double-blind trial (NORA)

OBJECTIVE: To compare the safety/tolerability of abacavir and nevirapine in HIV-infected adults starting antiretroviral (ARV) therapy in Uganda. METHODS: Twenty-four-week randomized double-blind trial conducted with 600 symptomatic ARV-naive adults with CD4 <200 cells/mm(3) allocated to zidovudin...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635484/
https://www.ncbi.nlm.nih.gov/pubmed/18290996
http://dx.doi.org/10.1111/j.1365-3156.2007.01973.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635484/
https://www.ncbi.nlm.nih.gov/pubmed/18290996
http://dx.doi.org/10.1111/j.1365-3156.2007.01973.x

Ejemplares similares